[引用][C] Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta …

J Chiramel, A Backen, R Pihlak, A Lamarca… - International Journal of …, 2017 - cir.nii.ac.jp
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with
Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis | CiNii Research CiNii …

Targeting the epidermal growth factor receptor in addition to chemotherapy in patients with advanced pancreatic cancer:: a systematic review and meta-analysis

J Chiramel, A Backen, R Pihlak… - International …, 2017 - research.manchester.ac.uk
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a worse prognosis. A systematic …

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

J Chiramel, AC Backen, R Pihlak… - International …, 2017 - search.ebscohost.com
Overexpression of epidermal growth factor receptors (EGFR) occurs in > 90% of
pancreatic ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A …

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

J Chiramel, AC Backen, R Pihlak… - … Journal of Molecular …, 2017 - europepmc.org
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …